Document is current
Any future updates will be listed below
-
Authors
Mestre, Tiago A. https://orcid.org/0000-0002-6973-7479
Stebbins, Glenn T. https://orcid.org/0000-0001-7905-9336
Stephenson, Diane
Dexter, David https://orcid.org/0000-0002-7974-9588
Lee, Karen K.
Xiao, Yuge
Dam, Tien
Kopil, Catherine M.
Simuni, Tanya https://orcid.org/0000-0002-2347-1644
-
Funding
Funding for this research was provided by:
The Michael J. Fox Foundation
- License Information
-
More Information
Article History
Received: 1 August 2023
Accepted: 25 April 2024
First Online: 14 May 2024
Competing interests
: Tiago A. Mestre: consulting and Advisory Board Membership with honoraria: Abbvie, International Parkinson and Movement Disorder Society, AAN, Abbvie, CHDI Foundation/Management, Sunovion, Valeo Pharma, Roche, nQ Medical, Medtronic. Grants and Research: EU Joint Program - Neurodegenerative Disease Research, uOBMRI, Roche, Ontario Research Fund, CIHR, Michael J. Fox Foundation for Parkinson’s Research, Parkinson Canada, PDF/PSG, LesLois Foundation, Parkinson Research Consortium and Brain Canada. Salary: UOMA. Glenn Stebbins: consulting and Advisory Board Membership with honoraria: Adamas Pharmaceuticals, CHDI Management, Inc., Cleveland Clinic Foundation, Huntington Study Group, Neurocrine Biosciences, Inc., Pfizer, Inc., Tools-4-Patients. Grants and Research: Critical Path Institute, Department of Defense, Dystonia Coalition, CHDI, International Parkinson and Movement Disorder Society, Michael J. Fox Foundation for Parkinson’s Research, Ottawa Hospital Research Institute. Honoraria: Alzheimer’s Association, Critical Path Institute, International Parkinson and Movement Disorder Society, Michael J. Fox Foundation for Parkinson’s Research. Diane Stephenson, David Dexter, Karen K Lee: no conflicts to disclose. Yuge Xiao: employee of The Michael J. Fox Foundation for Parkinson’s Research. No other disclosures. Tien Dam: employee of Neumora Therapeutics, Past employee of Biogen during preparation of this manuscript. Catherine M. Kopil: employee of The Michael J. Fox Foundation for Parkinson’s Research. No other disclosures. Tanya Simuni: consulting and Advisory Board Membership with honoraria: 4D Pharma, Acadia, AcureX, AskBio, Amneal, Blue Rock Therapeutics, Caraway Therapeutics, Critical Path for Parkinson’s Consortium (CPP), Denali, Michael J Fox Foundation, Neuroderm, Sanofi, Sinopia, Sunovion, Roche, Takeda, UCB, VanquaBio. Grants and research: Amneal, Biogen, Roche, Neuroderm, Sanofi, Prevail and UCB and an investigator for NINDS, MJFF, Parkinson’s Foundation.
